Quality of Life and Sexuality in Patients With Prostate Cancer

NCT02961686 | Withdrawn DMC

• 1 other identifier: 1635
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The trial is to describe quality of life in patients affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation.

Conditions

Quality of Life

Outcome Measures

Primary Outcomes (1)

• Quality of life measurement

  Evaluation of the quality of life with FACT-P test in patient affected by prostate cancer treated with exclusive radiotherapy and submitted to psychological and andrologic evaluation

  2.5 years

Study Arms (1)

Patients with prostate cancer

Patients affected by prostate cancer and treated with a multidisciplinary approach that comprise exclusive radiotherapy, psychological and andrologic evaluation.

Radiation: Patients affected by prostate cancer

Interventions

Patients affected by prostate cancer RADIATION

Patients affected by prostate cancer and treated with a multidisciplinary approach: it includes exclusive radiotherapy, psychological and andrologic evaluation.

Patients with prostate cancer

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients affected by prostate cancer

You may qualify if:

• Age 18-75 years.
• Histologically-proven of prostate cancer
• Indication to radical radiotherapy on prostate/ prostate + seminal vesicles / prostate + seminal vesicles + pelvic lymph nodes
• Informed consent

You may not qualify if:

• Other coexisting malignancies, uncontrolled intercurrent illness, active infectious processes, and exudative, bloody, or cytologically malignant effusions excluded patients from the trial.
• Previous surgery for prostate cancer, severe cardiac or vascular pathology
• Other major surgery in the preceding year or currently undergoing psychiatric care or psychological counseling.

Sponsors & Collaborators

• Istituto Clinico Humanitas: lead

Study Sites (1)

Humanitas Research Hospital

Rozzano, Milan, 20089, Italy

Location

Study Officials

• Ciro Franzese

  Istituto Clinico Humanitas

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Medical Doctor

Study Record Dates

• First Submitted: November 9, 2016
• First Posted: November 11, 2016
• Study Start: July 16, 2019
• Primary Completion: July 16, 2019
• Study Completion: July 16, 2019
• Last Updated: July 23, 2019

Record last verified: 2019-07

Data Sharing

• IPD Sharing: Will not share

Locations

IT (1)